AGS Health Limited IPO

AGS Health Limited IPO

Bidding period

To be announced

Bid price

To be announced

Listing on

To be announced

Listing date

To be announced

Lot size

To be announced

Issue size

To be announced


Minimum investment

To be announced

Maximum investment

To be announced

Open Demat Account
Open Demat Account

AGS Health Limited IPO financials

Particulars

For the period ending in March 2025 (in ₹ million)

Total assets ₹1,106.80
Total liabilities ₹1,106.80
Total expenditure ₹1,023.86
Total revenue ₹1,212.63
Profit after tax ₹142.93
EBITDA ₹254.41
Adjusted EBITDA ₹0.00

AGS Health Limited shareholder pattern

Pre-issue Post-issue
Promoter group 0.0 0.0
Public group 100.0 100.0

AGS Health Limited strengths and risks

Information currently unavailable

  • Leader in the Large, Resilient and Fast-Growing U.S. Healthcare RCM Market.

  • A Leading, Specialized End-to-End Platform Servicing the Full RCM Value Chain.

  • Scalable Suite of AI-led Technology Solutions Powered by Proprietary Platforms and Specialized Tools.

  • Established Direct Customer Relationships with Large U.S. Healthcare Systems.

  • Global Delivery Model Delivering Consistent Quality Combined with Cost-Effective Configurable Solutions.

  • Industry-Leading Financial Profile with Track Record of Growth.

  • Seasoned Management Team with Deep U.S. Healthcare Expertise.

  • Consequent to the completion of the Acquisition, the Company is responsible for overseeing and managing its consolidated business operations within and outside of India. Although the AGS business has historically been managed as a single group, this formal consolidation of oversight may present new structural and administrative challenges. The company may faces difficulties managing and administering an internationally dispersed business and may not be able to achieve operational efficiencies, which could adversely affect its business, results of operations or cash flows.

  • The Unaudited Proforma Financial Information included in this Updated Draft Red Herring Prospectus-I is not indicative of the company's future financial condition, results of operations or cash flows.

  • The U.S. healthcare industry is regulated and if its fails to comply with U.S. federal and state healthcare laws and regulations applicable to the company customers' operations, its could incur financial penalties, be required to make operational changes or experience adverse publicity, which could harm the company's business.

  • The company's revenues are dependent on its ability to maintain and expand existing customer relationships and the company's ability to attract new customers. As of March 31, 2026, its had 149 customers on a consolidated restated basis. On a proforma basis, as of March 31, 2026, 2025 and 2024, the company had 149, 142 and 144 customers respectively. A loss of one or more customers could have an adverse impact on its results of operations, financial condition and cash flows.

  • The company is dependent on its top 10 customers. In Fiscal 2026, 2025 and 2024, revenue from the company's top 10 customers was Rs. 12,915.31 million, Rs. 10,301.09 million and Rs. 7,519.07 million and accounted for 59.67%, 57.87% and 54.56% of its revenue from operations, respectively, on a proforma basis. The loss of any of these customers could reduce the company's revenues and may adversely impact its business, financial condition, results of operations, cash flows and prospects.

  • All of the company's revenues are derived from U.S.-based organizations in the healthcare industry, and as a result, the company is subject to the risks of sector and geographic concentration and any legislative or regulatory changes to the U.S. healthcare industry.

  • If the company security measures or those of its vendors fails or are breached and unauthorized access to the company employees, contractors, or customers' data is obtained, its platform may be perceived as insecure, the company may incur liabilities, including through private litigation or regulatory action, and its business, results of operations, cash flows and financial condition may be adversely affected.

  • Its industry is highly competitive, and the company may not be able to compete effectively.

  • The company's business is solely focused on the U.S. healthcare industry and its growth depends, in part, on the continued offshore outsourcing of RCM solutions by U.S. healthcare providers. If the dependency of the company customers on outsourcing RCM solutions from offshore suppliers like it reverses or the quantum of such outsourcing reduces, the company sales could be affected which may adversely affect its business, financial condition, cash flows and results of operations.

  • Pursuant to an external financing facility availed by the company's Promoter, BCP Topco, 100% of the equity share capital of its Promoter (held by BCP Asia II HoldCo VIII Pte. Ltd.) is subject to security interest created to secure such external financing facility. In case of an event of default and consequent invocation of security, there may be a change in control, which may adversely impact the company's business.

How to check the allotment status of the AGS Health Limited IPO?

To check the IPO allotment status, follow these steps:

 

  1. Visit the official website of the IPO’s registrar.
  2. Go to the IPO allotment status page.
  3. Select the ‘AGS Health Limited’ from the list of available IPOs.
  4. Enter your PAN, Demat ID, or application number.
  5. Click on ‘Submit’ or ‘Check Status’ to view your allotment details.

Alternatively, you can also check the allotment status on stock exchange websites such as the NSE or BSE.

Read more Read less

AGS Health Limited IPO registrar

MUFG Intime India Pvt Ltd

Phone number +91 810 811 4949
E-mail ID agshealth.ipo@in.mpms.mufg.com
Website https://in.mpms.mufg.com

AGS Health Limited IPO reservation

QIB shares offered

0 (0.0%)

NII (HNI) shares offered

0 (0.0%)

Retail shares offered

0 (0.0%)

Anchor investor shares offered

0 (0.0%)

Total shares offered

0

Total shares with anchor investor

0

AGS Health Limited IPO lead manager

  • ICICI Securities Limited
  • Jefferies India Private Limited
  • JM Financial Limited
  • J.P. Morgan India Private Limited
  • Nomura Financial Advisory & Securities (I) Pvt Ltd

Explore other IPOs

How to apply for an IPO with Bajaj Broking?

adafafds
 
 
  • Log in to the Bajaj Broking trading platform and select ‘IPO’ from the menu.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen IPO.
  • Enter the quantity and your UPI ID.
  • Submit your application—and you're done!

Frequently asked questions

What is the listing date for the AGS Health Limited IPO?

The listing date for the AGS Health Limited IPO is unknown.

What is the issue size of AGS Health Limited IPO?

The issue size of the AGS Health Limited IPO is unknown cr.

What is the minimum lot size needed for AGS Health Limited IPO?

The minimum lot size for AGS Health Limited IPO is unknown

When does the AGS Health Limited open and close?

AGS Health Limited IPO is open from unknown to unknown.

How can I apply for the AGS Health Limited IPO?

To apply for the AGS Health Limited, follow the steps given below:

  • Log in to your Bajaj Broking trading account and navigate to the current IPOs section.
  • Browse the list of open IPOs and click ‘Apply’ for your chosen PO.
  • Enter the quantity and your UPI ID. You will receive a mandate notification to block funds in your UPI app.
SHOW MORE SHOW LESS

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in securities market are subject to market risk, read all the related documents carefully before investing. Brokerage will not exceed the SEBI prescribed limit. All leveraged intraday positions will be squared off the same day. There is no restriction on withdrawal of unutilised margin amount. Trade Recommendations are research-calls provided under the SEBI Research Analyst guidelines.
Visit https://www.bajajbroking.in/disclaimer for complete disclaimer.

Securities market Products/services are made available only at the discretion of BFSL and subject to the individual contractual terms and conditions of the respective Securities market products/services. You shall be the sole owner of any decision to invest in any BFSL's Securities market products/services.

Securities market products/services may be withdrawn or amended at any time by BFSL without notice and your recourse in such case would be directly to reach out BFSL at connect@bajajfinserv.in or 1800 833 8888.

Powered by Bajaj Financial Securities Limited (Bajaj Broking)